Rare leukemia targeted by modifying patients’ immune cells – Litchfield County Times
Litchfield County Times |
Rare leukemia targeted by modifying patients’ immune cells
Litchfield County Times Turning the T cells into CAR–T cells helps by targeting the CD19 marker on the B cells. “CD19 happens to be a pretty good target for cancer technology because it’s only on B cells,” Gore said. “These new CAR–T cells latch onto the leukemia cells.”. |
IFLScience |
Stem Cell Implant Is Being Trialled To “Cure” Type 1 Diabetes
IFLScience A groundbreaking attempt to “cure” Type 1 diabetes with stem cells began last week. Embryonic stem cell implants were given to two people, one in the US and one in Canada, with high-risk Type 1 diabetes. The researchers hope that this will help the … This Scientific Breakthrough Could Be the Next Miracle Cure for Type 1 DiabetesReader’s Digest We’re One Step Closer to Curing Type 1 Diabetes With This First-Ever Stem Cell ImplantGears Of Biz Diabetes Cure 2017: Scientists May Have Found Treatment for Type-1 ConditionChristian Post |
Los Angeles Times |
Immunotherapy Shown Safe in Type 1 Diabetes Clinical Trial
WebMD The immunotherapy also showed signs of helping to keep insulin production steady in people newly diagnosed with the disease, the study authors said. However, because this was a placebo-controlled safety trial, there weren’t enough people included to … Immunotherapy succeeds in thwarting Type-1 diabetes in studyLos Angeles Times Immunotherapy for Type 1 Diabetes Safe, Promising in Small StudyMedscape Immunotherapy found safe for type 1 diabetes in landmark trialMedical News Today FierceBiotech –The Scientist –Yahoo Style UK all 111 news articles » |
|
Testing the safety of immunotherapy in diabetes
FierceBiotech Diabetes occurs when the T cells of the immune system destroy beta cells in the pancreas that produce insulin. Diabetes researchers have long been interested in using immunotherapy techniques to tamp down this wayward immune activity, but they’ve … |